These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 399578)

  • 1. Do leprosy patients in Papua New Guinea take their dapsone?
    Ree GH; Taylor VE
    P N G Med J; 1979; 22(2):145-7. PubMed ID: 399578
    [No Abstract]   [Full Text] [Related]  

  • 2. Secondary dapsone-resistant leprosy in Shanghai Municipality.
    Ji BH; Chen JK; Zhang JL; Hou YH; Ni GX; Zhang RB
    Lepr Rev; 1983 Sep; 54(3):197-202. PubMed ID: 6355724
    [No Abstract]   [Full Text] [Related]  

  • 3. Reply: recommending drug regimens to smear negative MB cases after prolonged dapsone monotherapy.
    Noordeen SK
    Lepr Rev; 1991 Sep; 62(3):340. PubMed ID: 1795596
    [No Abstract]   [Full Text] [Related]  

  • 4. Dapsone-resistant Mycobacterium leprae in a patient receiving dapsone in low doses.
    Browne SG
    Int J Lepr Other Mycobact Dis; 1969; 37(3):296-301. PubMed ID: 4906048
    [No Abstract]   [Full Text] [Related]  

  • 5. Primary dapsone-resistant leprosy in Cebu, Philippines.
    Guinto RS; Cellona RV; Fajardo TT; de la Cruz EC
    Int J Lepr Other Mycobact Dis; 1981 Dec; 49(4):427-30. PubMed ID: 7042607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of the multiplication of dapsone-resistant strains of Mycobacterium leprae in mice. Subcommittee on Clinical Trials of the C hemotherapy of Leprosy (THELEP) Scientific Working Group of UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases.
    Lepr Rev; 1988 Mar; 59(1):5-10. PubMed ID: 3294541
    [No Abstract]   [Full Text] [Related]  

  • 7. Combined clofazimine- and dapsone-resistant leprosy. A case report.
    Kar HK; Bhatia VN; Harikrishnan S
    Int J Lepr Other Mycobact Dis; 1986 Sep; 54(3):389-91. PubMed ID: 3528345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of dapsone in eliminating M. leprae from the skin of lepromatous patients, a study of 609 cases.
    Koticha KK; Sane AB
    Int J Lepr Other Mycobact Dis; 1971; 39(4):829-37. PubMed ID: 4949310
    [No Abstract]   [Full Text] [Related]  

  • 9. Primary dapsone-resistant leprosy in San Francisco.
    Gelber RH
    Int J Lepr Other Mycobact Dis; 1984 Dec; 52(4):471-4. PubMed ID: 6399067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [2 cases of paucibacillary leprosy resistant to dapsone].
    Janssens L
    Acta Leprol; 1982; (86-87):181-3. PubMed ID: 6815986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The continuous bacteremia of lepromatous leprosy.
    Drutz DJ; Chen TS; Lu WH
    N Engl J Med; 1972 Jul; 287(4):159-64. PubMed ID: 4555967
    [No Abstract]   [Full Text] [Related]  

  • 12. Survey of primary dapsone-resistant leprosy.
    Wang HY; Li WZ; Yang LH; Huang HS; Lu WQ; Yu LC
    Proc Chin Acad Med Sci Peking Union Med Coll; 1986; 1(3):173-5. PubMed ID: 3321049
    [No Abstract]   [Full Text] [Related]  

  • 13. [New WHO recommendations for the treatment of leprosy].
    Acta Leprol; 1997; 10(4):189. PubMed ID: 9527754
    [No Abstract]   [Full Text] [Related]  

  • 14. [Prevalence of dapsone-resistant leprosy in Burundi. Temporary results].
    Bourland J; Van Loo L; Pattyn SR
    Acta Leprol; 1982; (86-87):29-33. PubMed ID: 6815995
    [No Abstract]   [Full Text] [Related]  

  • 15. Low dose dapsone therapy in lepromatous leprosy.
    Karat AB
    Lepr Rev; 1975 Jun; 46(2 Suppl):89-92. PubMed ID: 1100970
    [No Abstract]   [Full Text] [Related]  

  • 16. Application of polymerase chain reaction for the detection of Mycobacterium leprae DNA in specimens from treated leprosy patients.
    Rafi A; Donoghue HD; Stanford JL
    Int J Lepr Other Mycobact Dis; 1995 Mar; 63(1):42-7. PubMed ID: 7730718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [localization and topographic distribution of Hansen's bacilli at the level of leprotic lesions].
    Le-Kinh-Due ; Nguyen-Nguyen ; Dô-Trong-Lâm
    Dermatol Monatsschr; 1971 Apr; 157(4):225-31. PubMed ID: 4938032
    [No Abstract]   [Full Text] [Related]  

  • 18. Primary dapsone-resistant Hansen's disease in California. Experience with over 100 Mycobacterium leprae isolates.
    Gelber RH; Rea TH; Murray LP; Siu P; Tsang M; Byrd SR
    Arch Dermatol; 1990 Dec; 126(12):1584-6. PubMed ID: 2256685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenosine triphosphate content of Mycobacterium leprae from leprosy patients.
    Dhople AM
    Int J Lepr Other Mycobact Dis; 1984 Jun; 52(2):183-8. PubMed ID: 6373626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ten years of dapsone in lepromatous leprosy: clinical, bacteriological and histological assessment and the finding of viable leprosy bacilli.
    Waters MF; Rees RJ; McDougall AC; Weddell AG
    Lepr Rev; 1974 Dec; 45(4):288-98. PubMed ID: 4613977
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.